Annual Net Income
-$740.87 M
-$159.08 M-27.34%
31 December 2022
Summary:
Mirati Therapeutics annual net profit is currently -$740.87 million, with the most recent change of -$159.08 million (-27.34%) on 31 December 2022. During the last 3 years, it has fallen by -$382.93 million (-106.98%).MRTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$161.90 M
+$15.01 M+8.48%
30 September 2023
Summary:
Mirati Therapeutics quarterly net profit is currently -$161.90 million, with the most recent change of +$15.01 million (+8.48%) on 30 September 2023.MRTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$725.88 M
+$11.66 M+1.58%
30 September 2023
Summary:
Mirati Therapeutics TTM net profit is currently -$725.88 million, with the most recent change of +$11.66 million (+1.58%) on 30 September 2023.MRTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -107.0% | -102.2% | -50.1% |
| 5 y5 years | -652.8% | -198.9% | -330.3% |
MRTX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | >+9999.0% | -2194.0% | >+9999.0% |
Mirati Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$161.90 M(-8.5%) | -$725.88 M(-1.6%) |
| June 2023 | - | -$176.91 M(-4.2%) | -$737.53 M(+0.1%) |
| Mar 2023 | - | -$184.59 M(-8.8%) | -$737.07 M(-0.5%) |
| Dec 2022 | -$740.87 M(+27.3%) | -$202.47 M(+16.7%) | -$740.87 M(+0.4%) |
| Sept 2022 | - | -$173.56 M(-1.6%) | -$738.01 M(+14.5%) |
| June 2022 | - | -$176.44 M(-6.3%) | -$644.50 M(+1.6%) |
| Mar 2022 | - | -$188.39 M(-5.6%) | -$634.35 M(+9.1%) |
| Dec 2021 | -$581.78 M(+62.5%) | -$199.62 M(+149.4%) | -$581.64 M(+20.3%) |
| Sept 2021 | - | -$80.05 M(-51.9%) | -$483.67 M(-1.6%) |
| June 2021 | - | -$166.28 M(+22.6%) | -$491.78 M(+20.9%) |
| Mar 2021 | - | -$135.68 M(+33.5%) | -$406.78 M(+13.7%) |
| Dec 2020 | -$357.94 M(+68.2%) | -$101.66 M(+15.3%) | -$357.75 M(+8.9%) |
| Sept 2020 | - | -$88.16 M(+8.5%) | -$328.48 M(+11.5%) |
| June 2020 | - | -$81.28 M(-6.2%) | -$294.49 M(+13.8%) |
| Mar 2020 | - | -$86.66 M(+19.7%) | -$258.75 M(+21.6%) |
| Dec 2019 | -$212.85 M(+116.3%) | -$72.38 M(+33.6%) | -$212.85 M(+26.2%) |
| Sept 2019 | - | -$54.17 M(+18.9%) | -$168.71 M(+18.8%) |
| June 2019 | - | -$45.54 M(+11.8%) | -$142.00 M(+14.4%) |
| Mar 2019 | - | -$40.75 M(+44.3%) | -$124.17 M(+26.2%) |
| Dec 2018 | -$98.42 M(+39.6%) | -$28.24 M(+2.8%) | -$98.42 M(+11.7%) |
| Sept 2018 | - | -$27.47 M(-0.9%) | -$88.13 M(+14.4%) |
| June 2018 | - | -$27.71 M(+84.8%) | -$77.01 M(+13.7%) |
| Mar 2018 | - | -$15.00 M(-16.4%) | -$67.74 M(-3.9%) |
| Dec 2017 | -$70.48 M(-15.2%) | -$17.95 M(+9.8%) | -$70.52 M(-2.5%) |
| Sept 2017 | - | -$16.35 M(-11.3%) | -$72.34 M(-4.1%) |
| June 2017 | - | -$18.44 M(+3.8%) | -$75.45 M(-4.5%) |
| Mar 2017 | - | -$17.77 M(-10.1%) | -$79.03 M(-4.9%) |
| Dec 2016 | -$83.14 M(+28.9%) | -$19.77 M(+1.6%) | -$83.14 M(+1.7%) |
| Sept 2016 | - | -$19.45 M(-11.7%) | -$81.75 M(+0.9%) |
| June 2016 | - | -$22.03 M(+0.6%) | -$81.03 M(+8.8%) |
| Mar 2016 | - | -$21.89 M(+19.1%) | -$74.46 M(+15.4%) |
| Dec 2015 | -$64.51 M(+47.7%) | -$18.38 M(-1.9%) | -$64.51 M(+14.1%) |
| Sept 2015 | - | -$18.73 M(+21.2%) | -$56.52 M(+21.8%) |
| June 2015 | - | -$15.46 M(+29.5%) | -$46.41 M(+10.6%) |
| Mar 2015 | - | -$11.94 M(+14.8%) | -$41.97 M(-3.9%) |
| Dec 2014 | -$43.68 M | -$10.39 M(+20.5%) | -$43.68 M(-1.9%) |
| Sept 2014 | - | -$8.63 M(-21.7%) | -$44.53 M(-31.8%) |
| June 2014 | - | -$11.01 M(-19.3%) | -$65.30 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$13.65 M(+21.3%) | -$62.30 M(+17.8%) |
| Dec 2013 | -$52.87 M(+160.6%) | -$11.25 M(-61.7%) | -$52.87 M(+10.3%) |
| Sept 2013 | - | -$29.40 M(+266.9%) | -$47.93 M(+95.8%) |
| June 2013 | - | -$8.01 M(+90.0%) | -$24.48 M(+15.8%) |
| Mar 2013 | - | -$4.22 M(-33.1%) | -$21.15 M(+4.2%) |
| Dec 2012 | -$20.29 M(+112.9%) | -$6.31 M(+6.1%) | -$20.29 M(+15.2%) |
| Sept 2012 | - | -$5.95 M(+27.1%) | -$17.61 M(+20.4%) |
| June 2012 | - | -$4.68 M(+39.4%) | -$14.63 M(+27.5%) |
| Mar 2012 | - | -$3.36 M(-7.5%) | -$11.47 M(+17.9%) |
| Dec 2011 | -$9.53 M(-35.0%) | -$3.63 M(+22.3%) | -$9.73 M(+15.2%) |
| Sept 2011 | - | -$2.97 M(+95.2%) | -$8.44 M(-16.7%) |
| June 2011 | - | -$1.52 M(-6.0%) | -$10.14 M(-14.0%) |
| Mar 2011 | - | -$1.62 M(-31.0%) | -$11.80 M(-19.4%) |
| Dec 2010 | -$14.65 M(-35.0%) | -$2.34 M(-49.8%) | -$14.64 M(-16.7%) |
| Sept 2010 | - | -$4.67 M(+46.9%) | -$17.57 M(-2.3%) |
| June 2010 | - | -$3.18 M(-28.6%) | -$17.97 M(-13.4%) |
| Mar 2010 | - | -$4.45 M(-15.5%) | -$20.75 M(-1.8%) |
| Dec 2009 | -$22.53 M(+207.4%) | -$5.27 M(+3.9%) | -$21.14 M(+159.8%) |
| Sept 2009 | - | -$5.07 M(-14.9%) | -$8.14 M(+30.8%) |
| June 2009 | - | -$5.96 M(+23.1%) | -$6.22 M(-17.1%) |
| Mar 2009 | - | -$4.84 M(-162.6%) | -$7.51 M(-3.1%) |
| Dec 2008 | -$7.33 M(-67.0%) | $7.73 M(-345.0%) | -$7.75 M(-65.7%) |
| Sept 2008 | - | -$3.16 M(-56.4%) | -$22.59 M(-9.8%) |
| June 2008 | - | -$7.24 M(+42.5%) | -$25.03 M(+6.0%) |
| Mar 2008 | - | -$5.08 M(-28.5%) | -$23.62 M(+10.6%) |
| Dec 2007 | -$22.24 M(+245.1%) | -$7.11 M(+27.0%) | -$21.36 M(+32.9%) |
| Sept 2007 | - | -$5.60 M(-4.0%) | -$16.07 M(+107.0%) |
| June 2007 | - | -$5.83 M(+106.7%) | -$7.76 M(+40.7%) |
| Mar 2007 | - | -$2.82 M(+54.9%) | -$5.52 M(-12.3%) |
| Dec 2006 | -$6.44 M(-51.0%) | -$1.82 M(-167.3%) | -$6.29 M(-27.6%) |
| Sept 2006 | - | $2.71 M(-175.6%) | -$8.70 M(-41.1%) |
| June 2006 | - | -$3.58 M(-0.4%) | -$14.75 M(+4.1%) |
| Mar 2006 | - | -$3.60 M(-14.8%) | -$14.17 M(+9.8%) |
| Dec 2005 | -$13.17 M(+43.9%) | -$4.22 M(+26.0%) | -$12.91 M(+48.6%) |
| Sept 2005 | - | -$3.35 M(+11.6%) | -$8.69 M(+62.8%) |
| June 2005 | - | -$3.00 M(+28.6%) | -$5.34 M(+128.6%) |
| Mar 2005 | - | -$2.33 M | -$2.33 M |
| Dec 2004 | -$9.15 M(+116.7%) | - | - |
| Dec 2003 | -$4.22 M | - | - |
FAQ
- What is Mirati Therapeutics annual net profit?
- What is the all time high annual net income for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Mirati Therapeutics?
- What is Mirati Therapeutics TTM net profit?
- What is the all time high TTM net income for Mirati Therapeutics?
What is Mirati Therapeutics annual net profit?
The current annual net income of MRTX is -$740.87 M
What is the all time high annual net income for Mirati Therapeutics?
Mirati Therapeutics all-time high annual net profit is -$4.22 M
What is Mirati Therapeutics quarterly net profit?
The current quarterly net income of MRTX is -$161.90 M
What is the all time high quarterly net income for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly net profit is $7.73 M
What is Mirati Therapeutics TTM net profit?
The current TTM net income of MRTX is -$725.88 M
What is the all time high TTM net income for Mirati Therapeutics?
Mirati Therapeutics all-time high TTM net profit is -$2.33 M